Systematic quantification of peptides/proteins in urine using selected reaction monitoring

Proteomics

Volumn 11, Issue 6, 2011, Pages 1135-1147

  Selevsek, Nathalie ^a   Matondo, Mariette ^a   Carbayo, Marta Sanchez ^b   Aebersold, Ruedi ^a,c   Domon, Bruno ^a,d  

^a ETH ZURICH   (Switzerland)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Biomarkers; Bladder cancer; Selected reaction monitoring; Technology; Urine

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; STABLE ISOTOPE;

ACCURACY; ADULT; AGED; ARTICLE; BLADDER CANCER; BODY FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOTOPE DILUTION ASSAY; ISOTOPE LABELING; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN URINE LEVEL; REPRODUCIBILITY; SELECTED REACTION MONITORING; URINALYSIS;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ANTIGENS, CD44; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; CLUSTERIN; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEINURIA; PROTEOMICS; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE;

EID: 79952308635     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000599     Document Type: Article

References (25)

1. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
2. Keshishian, H., Addona, T., Burgess, M., Mani, D. R. et al., Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2009, 8, 2339-2349.
3. Stahl-Zeng, J., Lange, V., Ossola, R., Eckhardt, K. et al., High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell. Proteomics 2007, 6, 1809-1817.
4. Anderson, L., Hunter, C. L., Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics 2006, 5, 573-588.
5. States, D. J., Omenn, G. S., Blackwell, T. W., Fermin, D. et al., Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat. Biotechnol. 2006, 24, 333-338.
6. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
7. Ng, T. K., Vasilareas, D., Mitterdorfer, A. J., Maher, P. O., Lalak, A., Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice. Br. J. Urol. Int. 2005, 95, 545-548.
8. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
9. Thongboonkerd, V., Practical points in urinary proteomics. J. Proteome Res. 2007, 6, 3881-3890.
10. Epstein, J. I., Amin, M. B., Reuter, V. R., Mostofi, F. K., The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 1998, 22, 1435-1448.
11. Orenes-Pinero, E., Barderas, R., Rico, D., Casal, J. I. et al., Serum and tissue profiling in bladder cancer combining protein and tissue arrays. J. Proteome Res. 2010, 9, 164-173.
12. Chuang, C. K., Liao, S. K., Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas. Anticancer Res. 2003, 23, 4635-4639.
13. Miyake, H., Gleave, M., Kamidono, S., Hara, I., Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence. Urology 2002, 59, 150-154.
14. Osman, I., Bajorin, D. F., Sun, T. T., Zhong, H. et al., Novel blood biomarkers of human urinary bladder cancer. Clin. Cancer Res. 2006, 12, 3374-3380.
15. Kageyama, S., Isono, T., Matsuda, S., Ushio, Y. et al., Urinary calreticulin in the diagnosis of bladder urothelial carcinoma. Int. J. Urol. 2009, 16, 481-486.
16. Deutsch, E. W., Lam, H., Aebersold, R., PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep. 2008, 9, 429-434.
17. Kiyonami, R., Schoen, A., Prakash, A., Peterman, S. et al., Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol. Cell. Proteomics. 2010, In press.
18. Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J. et al., Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol. 2009, 27, 633-641.
19. Eissa, S., Zohny, S. F., Swellam, M., Mahmoud, M. H. et al., Comparison of CD44 and cytokeratin 20 mRNA in voided urine samples as diagnostic tools for bladder cancer. Clin. Biochem. 2008, 41, 1335-1341.
20. Jones, S. E., Jomary, C., Clusterin. Int. J. Biochem. Cell. Biol. 2002, 34, 427-431.
21. Steinberg, J., Oyasu, R., Lang, S., Sintich, S. et al., Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin. Cancer Res. 1997, 3, 1707-1711.
22. Parczyk, K., Pilarsky, C., Rachel, U., Koch-Brandt, C., Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J. Cancer Res. Clin. Oncol. 1994, 120, 186-188.
23. Redondo, M., Villar, E., Torres-Munoz, J., Tellez, T. et al., Overexpression of clusterin in human breast carcinoma. Am. J. Pathol. 2000, 157, 393-399.
24. Canesin, G., Gonzalez-Peramato, P., Palou, J., Urrutia, M. et al., Galectin-3 expression is associated with bladder cancer progression and clinical outcome. Tumour Biol. 2010, 31, 277-285.
25. Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G. et al., Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J. Proteome Res. 2009, 8, 268-281.